Document ID: chunk:federal_register_of_legislation:F2024C01037:front:0:p6
Version: federal_register_of_legislation:F2024C01037
Segment Type: other
Provision Reference: 
Character Range: 14312–17154

report
  The APVMA must include in its annual report a list of:
 (a) the standards made under section 6E of the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994 during the period to which the annual report relates; and
 (b) the standards made under section 6E that were varied by the APVMA during the period to which the annual report relates.

1A.3  Performance indicators for inclusion in annual report
  For the purposes of paragraph 61(b) of the Act, the following performance indicators are prescribed:
 (a) the number of reconsiderations commenced by the APVMA under section 31 of the Schedule to the Agricultural and Veterinary Chemicals Code Act 1994 (the Agvet Code Act) during the period to which the annual report relates;
 (b) the number of reconsiderations concluded by the APVMA under Division 4 of Part 2 of the Schedule to the Agvet Code Act during that period;
 (c) brief details of the progress of reconsiderations that were scheduled to progress in that period;
 (ca) a summary of any action taken by the APVMA under section 99 of the Schedule to the Agvet Code Act during that period;
 (d) the number of applications mentioned in each item of Part 2 of Schedule 6 of the Agricultural and Veterinary Chemicals Code Regulations 1995 that were:
 (i) made under the Schedule to the Agvet Code Act during that period; and
 (ii) not determined within the period required for the application by regulations made under section 165 of that Schedule;
 (e) the number of reports (known as adverse experience reports) received by the APVMA during that period;
 (f) the number of adverse experience reports mentioned in paragraph (e) that the APVMA determined were related to each of the following:
 (i) human health;
 (ii) environment;
 (iii) animal health;
 (iv) crop health;
 (v) efficacy for agricultural chemical products or veterinary chemical products;
 (g) a summary of any action taken by the APVMA during that period in relation to adverse experience reports.
Note: Adverse experience reports are received under the Adverse Experience Reporting Program (AERP) which is a post‑registration quality assurance program established by the APVMA.

Part 2—Providing information about certain active constituents and chemical products

2.05  Prescribed international agreements (Act s 69CA(1))
  Each of the following is a prescribed international agreement for the purposes of subsection 69CA(1) of the Act:
 (a) the Rotterdam Convention;
 (b) the Stockholm Convention.

2.10  Prescribed chemicals (Act s 69CA(2))
  A chemical is a prescribed active constituent or prescribed chemical product for the purposes of subsection 69CA(2) of the Act if:
 (a) there is an item in Schedule 1 for the chemical; and
 (b) the item describes the chemical as a prescribed active constituent or a prescribed chemical product for